| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
350,000,000 |
| Market
Cap: |
5.18(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$13.68 - $20.99 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch + Lomb is an eye health company. Co. operates in three segments: Vision Care/Consumer Health Care, which includes both a contact lens business and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins; Ophthalmic Pharmaceuticals, which consists of a line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, dry eyes and retinal diseases; and Surgical, which consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts and vitreous and retinal eye conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
39,550,357 |
| Total Sell Value |
$0 |
$0 |
$0 |
$674,531,339 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bailey A Robert D |
EVP & Chief Legal Officer |
• • – |
2024-04-24 |
4 |
D |
$14.90 |
$146,586 |
D/D |
(9,838) |
144,219 |
|
- |
|
| Stewart Andrew J. |
See remarks |
• • – |
2024-04-24 |
4 |
D |
$14.90 |
$58,751 |
D/D |
(3,943) |
45,985 |
|
- |
|
| Paulson John |
Director |
• • – |
2024-03-29 |
4 |
A |
$17.30 |
$21,867 |
D/D |
1,264 |
31,538 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2024-03-29 |
4 |
A |
$17.30 |
$26,867 |
D/D |
1,553 |
32,952 |
|
- |
|
| Robertson Russel C |
Director |
• • – |
2024-03-29 |
4 |
A |
$17.30 |
$25,621 |
D/D |
1,481 |
25,906 |
|
- |
|
| Ling Karen |
Director |
• • – |
2024-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,642 |
2,642 |
|
- |
|
| Bonnefoy Luc |
President,Surgical |
• • – |
2024-03-01 |
4 |
D |
$16.47 |
$18,084 |
D/D |
(1,098) |
58,169 |
|
- |
|
| Munsch Frederick |
SVP, Controller and CAO |
• • – |
2024-03-01 |
4 |
D |
$16.47 |
$16,388 |
D/D |
(995) |
57,126 |
|
- |
|
| Hashad Yehia |
EVP of R&D and CMO |
• • – |
2024-03-01 |
4 |
D |
$16.47 |
$35,295 |
D/D |
(2,143) |
102,271 |
|
- |
|
| Eldessouky Sam |
EVP and CFO |
• • – |
2024-03-01 |
4 |
D |
$16.47 |
$79,945 |
D/D |
(4,854) |
243,780 |
|
- |
|
| Eldessouky Sam |
EVP and CFO |
• • – |
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
50,335 |
248,634 |
|
- |
|
| Bonnefoy Luc |
President,Surgical |
• • – |
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
16,778 |
59,267 |
|
- |
|
| Bailey A Robert D |
EVP & Chief Legal Officer |
• • – |
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
33,557 |
154,057 |
|
- |
|
| Munsch Frederick |
SVP, Controller and CAO |
• • – |
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
18,183 |
58,121 |
|
- |
|
| Saunders Brent L |
CEO and Chair |
• • – |
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
187,919 |
562,919 |
|
- |
|
| Hashad Yehia |
EVP of R&D and CMO |
• • – |
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
20,973 |
104,414 |
|
- |
|
| Stewart Andrew J. |
See remarks |
• • – |
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
16,778 |
49,928 |
|
- |
|
| Bernier Nathalie D. |
Director |
• • – |
2023-12-29 |
4 |
A |
$17.06 |
$24,993 |
D/D |
1,465 |
34,629 |
|
- |
|
| Robertson Russel C |
Director |
• • – |
2023-12-29 |
4 |
A |
$17.06 |
$25,624 |
D/D |
1,502 |
24,425 |
|
- |
|
| Paulson John |
Director |
• • – |
2023-12-29 |
4 |
A |
$17.06 |
$21,871 |
D/D |
1,282 |
30,274 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2023-12-29 |
4 |
A |
$17.06 |
$26,870 |
D/D |
1,575 |
31,399 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2023-09-29 |
4 |
A |
$16.95 |
$26,866 |
D/D |
1,585 |
29,824 |
|
- |
|
| Bernier Nathalie D. |
Director |
• • – |
2023-09-29 |
4 |
A |
$16.95 |
$24,984 |
D/D |
1,474 |
33,164 |
|
- |
|
| Robertson Russel C |
Director |
• • – |
2023-09-29 |
4 |
A |
$16.95 |
$25,611 |
D/D |
1,511 |
22,923 |
|
- |
|
| Paulson John |
Director |
• • – |
2023-09-29 |
4 |
A |
$16.95 |
$21,866 |
D/D |
1,290 |
28,992 |
|
- |
|
81 Records found
|
|
Page 1 of 4 |
|
|
0.03 (0.2%) 
